U.S. Department of Health and Human Services

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Summit on Urinary Incontinence Clinical Research in Women

3/20/2014 12:00 AM
3/20/2014 12:00 AM
Natcher Conference Center

Event Details

​Meeting Background

Urinary incontinence in women is common, costly and consequential and associated with common medical conditions such as obesity, diabetes and cardiovascular disease. The NIDDK and NICHD have funded many treatment trials that have been widely published. The broad impact of the completed research on clinical care has not been considered. Is there more value to obtain from completed research?  Additionally, what are the future needs that will drive improvement in the care of women with urinary incontinence?

Meeting Objectives

To bring together health care professionals from a variety of disciplines, consumer advocates and governmental agencies with interest in the treatment of urinary incontinence to achieve the following goals:
  1. Determine the key scientific advances in the treatment of urinary incontinence in women made by NIH/NIDDK funded clinical research
  2. Identify the extent to which and how their findings have impacted treatment of patients, been adopted by health care professionals, other researchers and agencies
  3. Determine the audience-specific messages that will facilitate dissemination and uptake of the results of the discussed studies
  4. Define unmet needs in urinary incontinence research or empirical evidence to stimulate the submission of investigator initiated (R01) and other grant applications to the NIDDK  and other NIH institutes and government agencies to address challenges in the identification, diagnosis and treatment of urinary incontinence in women.  Studies of particular interest would have broad applicability to the affected population.


8:00 a.m.         Welcome
                        Robert Star, M.D., National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
                        Introduction: Driving Change in Sufferer and Clinician Behavior to Increase Diagnosis and Successful
                        Treatment of UI in Women
                        Tamara Bavendam, M.D., M.S., NIDDK
                        Overview – Epidemiology/Impact/Unmet Need
                        Sharon Tennstedt, Ph.D., RN, New England Research Institutes
9:00 a.m.         ATLAS Study
                        Holly Richter, M.D., Ph.D., The University of Alabama at Birmingham
9:20 a.m.         BE-DRI Study
                        Kathy Burgio, Ph.D., The University of Alabama at Birmingham
9:40 a.m.         ABC Study
                        Anthony Visco, M.D., Duke University
10:00 a.m.       Break
10:20 a.m.       SISTEr Study
                        Mike Albo, M.D., University of California, San Diego
10:40 a.m.       TOMUS Study
                        Mike Albo, M.D., University of California, San Diego
11:00 a.m.       PRIDE Study
                        Leslee Subak, M.D., University of California, San Francisco
11:20 a.m.       Discussion
12:00 p.m.       Lunch
1:00 p.m.         Breakout Groups
      • Key Messages From Completed Research
      • Future Research Needs
                        Group 1 – Nonsurgical Perspective
                        Group 2 – Surgical Perspective
2:40 p.m.         Report Back
3:20 p.m.         Establish Writing Group
3:30 p.m.         Adjournment



​​Click Final Summit on Urinary Incontinence Summary.pdfhere (PDF, 334 KB) to view the minutes.




  • Building 45, National Institutes of Health (NIH)
  • MD